Managing Myeloma
- 2010-07-29 - Higher Quality Response To Lenalidomide-Dexamethasone Combination Yields Better Prognosis For Relapsed And Refractory Multiple Myeloma Patients-Myeloma Beacon
- 2010-07-29 - Important News Flash: NCCN Practice Guidelines in Onclogy-Multiple Myeloma Have Been Updated! (v.1.2011): New Induction and Salvage Regimens Have Been Added, sFLC Assay Recommendation Extended to Initial Diagnostic Workup
- 2010-07-28 - Single-Agent Carfilzomib Continues To Show Promise For Relapsed And Refractory Multiple Myeloma
- 2010-07-23 - Bristol-Myers Squibb Halts Development of Tanespimycin-Myeloma Beacon
- 2010-07-21 - Onyx Pharmaceuticals Initiates a Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma-PR Newswire
- 2010-07-20 - First swine flu death in West Bengal was a Multiple Myeloma Patient
- 2010-07-19 - Heparin, Warfarin, And Aspirin Are Equally Effective In Preventing Blood Clots In Myeloma Patients Receiving Thalidomide (EHA 2010)
- 2010-07-16 - Abnormal Plasma Cells In The Blood May Indicate Aggressive And Treatment-Resistant Multiple Myeloma (EHA 2010)
- 2010-07-15 - New discovery brings hope to treatment of incurable blood cancer
- 2010-07-12 - Prevalence of bisphosphonate associated osteonecrosis of the jaw in multiple myeloma patients
- 2010-07-08 - Cancer patient loses insurance over 1 cent
- 2010-07-07 - Zoledronic acid superior to clodronate for skeletal-related events in newly diagnosed multiple myeloma
- 2010-07-06 - German Government Grants MorphoSys $1.26M to Progress Multiple Myeloma Antibody into Clinic
- 2010-07-06 - Scotte H. Manns Newspaper Advertising Executive at The Washington Post
- 2010-07-01 - Access the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) anywhere and at anytime through free NCCN Guidelines mobile apps for iPhone and Android.